ATRY (ATRY) News
Track canonical SquawkNews coverage tagged to ATRY, ATRY. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Atrys reports H1 2026 revenue up 9.4% and EBITDA up 21.3%
Atrys Health reported H1 2026 revenue of €77.7M, up 9.4%, with EBITDA up 21.3%. The company said net debt fell 79.2% after the ASPY sale and that full-year guidance was reaffirmed.
EARNINGS | Sep 10, 2026, 07:48 AM UTC
L
ATRY reports 1H 2026 revenue growth and EBITDA rise YoY
Atrys Health SA said 1H 2026 revenue grew YoY to €77.7M and EBITDA rose YoY. Net debt fell 79.2% after the Prevention segment sale; 2026 guidance was reaffirmed.
EARNINGS | Sep 10, 2026, 06:39 AM UTC
L
Atrys H1 Net Loss At €6.4 Mln
Atrys Health SA BME:ATRY:Source text
EQUITY | Sep 10, 2026, 06:28 AM UTC